These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36136264)

  • 1. Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective.
    Bahuguna P; Masaki E; Jeet G; Prinja S
    Appl Health Econ Health Policy; 2023 Jan; 21(1):131-140. PubMed ID: 36136264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the delivery costs of COVID-19 vaccination using the COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool: the Lao People's Democratic Republic experience.
    Yeung KHT; Kim E; Yap WA; Pathammavong C; Franzel L; Park YL; Cowley P; Griffiths UK; Hutubessy RCW
    BMC Med; 2023 Jul; 21(1):248. PubMed ID: 37424001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determinants of immunization coverage among children aged between 12 and 35 months: a nationwide cross-sectional study in Lao People's Democratic Republic.
    Ichimura Y; Yanagisawa N; Thandar MM; Pathammavong C; Phounphenghuk K; Nouanthong P; Tengbriacheu C; Khamphaphongphane B; Franzel-Sassanpour LE; Yang TU; Raaijmakers H; Ota T; Komada K; Hachiya M; Miyano S
    BMC Public Health; 2022 Dec; 22(1):2259. PubMed ID: 36463130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with routine immunization coverage of children under one year old in Lao People's Democratic Republic.
    Phoummalaysith B; Yamamoto E; Xeuatvongsa A; Louangpradith V; Keohavong B; Saw YM; Hamajima N
    Vaccine; 2018 May; 36(19):2666-2672. PubMed ID: 29606518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of typhoid vaccination in Lao PDR.
    Soukavong M; Luangasanatip N; Chanthavilay P; Teerawattananon Y; Dabak SV; Pan-Ngum W; Roberts T; Ashley EA; Mayxay M
    BMC Public Health; 2023 Nov; 23(1):2270. PubMed ID: 37978481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustaining essential health services in Lao PDR in the context of donor transition and COVID-19.
    Kim E; Park YL; Lo YR; Keoprasith B; Panyakeo S
    Health Policy Plan; 2024 Jan; 39(Supplement_1):i131-i136. PubMed ID: 38253449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
    Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
    Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
    Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
    BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Ortega-Sanchez IR; Mott JA; Kittikraisak W; Khanthamaly V; McCarron M; Keokhonenang S; Ounaphom P; Pathammavong C; Phounphenghack K; Sayamoungkhoun P; Chanthavilay P; Bresee J; Tengbriacheu C
    Vaccine; 2021 Dec; 39(52):7633-7645. PubMed ID: 34802790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach.
    Chanthavilay P; Reinharz D; Mayxay M; Phongsavan K; Marsden DE; Moore L; White LJ
    BMC Health Serv Res; 2016 Aug; 16(1):418. PubMed ID: 27549921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing seasonal influenza vaccine in low-income countries: an adverse events following immunization survey in the Lao People's Democratic Republic.
    Phengxay M; Mirza SA; Reyburn R; Xeuatvongsa A; Winter C; Lewis H; Olsen SJ; Tsuyuoka R; Khanthamaly V; Palomeque FS; Bresee JS; Moen AC; Corwin AL;
    Influenza Other Respir Viruses; 2015 Mar; 9(2):94-8. PubMed ID: 25598475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Rural Incentive Packages for Graduating Medical Students in Lao PDR.
    Keuffell E; Jaskiewicz W; Theppanya K; Tulenko K
    Int J Health Policy Manag; 2017 Jul; 6(7):383-394. PubMed ID: 28812834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
    Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
    Xeuatvongsa A; Mott JA; Khanthamaly V; Patthammavong C; Phounphenghak K; McKinlay M; Mirza S; Lafond KE; McCarron M; Corwin A; Moen A; Olsen SJ; Bresee JS
    Vaccine; 2019 May; 37(23):3002-3005. PubMed ID: 31027926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania.
    Vaughan K; Clarke-Deelder E; Tani K; Lyimo D; Mphuru A; Manzi F; Schütte C; Ozaltin A
    Vaccine; 2020 Nov; 38(48):7659-7667. PubMed ID: 33077300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and service utilisation associated with mental and substance use disorders in Lao People's Democratic Republic: findings from a cross-sectional survey.
    Charlson F; Diminic S; Choulamany C; Santomauro D; Raja S; Whiteford H
    Epidemiol Psychiatr Sci; 2019 Feb; 28(1):54-65. PubMed ID: 28735592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking financial flows for immunization in Honduras.
    Valdés W; Janusz CB; Molina Aguilera IB; Mendoza L; Díaz IY; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A85-92. PubMed ID: 25919182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
    Debellut F; Mkisi R; Masoo V; Chisema M; Mwagomba D; Mtenje M; Limani F; Mategula D; Zimba B; Pecenka C
    Vaccine; 2022 Mar; 40(12):1741-1746. PubMed ID: 35153097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.